Ardsley Advisory Partners LP Neurocrine Biosciences Inc Transaction History

Ardsley Advisory Partners LP

  • $564 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$86.8 - $118.57 $651,000 - $889,275
-7,500 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$83.82 - $101.5 $628,650 - $761,250
7,500 New
7,500 $676,000
Q4 2017

Feb 14, 2018
SELL
$58.53 - $77.59 $5.71 Million - $7.57 Million
-97,500 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$47.97 - $61.28 $4.44 Million - $5.67 Million
92,500 Added 1850.0%
97,500 $5.98 Million
Q2 2017

Sep 21, 2017
BUY
N/A
5,000
5,000 $230,000

Others Institutions Holding NBIX

# of Institutions
638
Shares Held
93.8M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $14.5B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Ardsley Advisory Partners LP Portfolio

Follow Ardsley Advisory Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Ardsley Advisory Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email